Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33389 | 125 | 28.3 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
1927 | 2 | FGF21//FIBROBLAST GROWTH FACTOR//FIBROBLAST GROWTH FACTOR 21 | 5824 |
33389 | 1 | PENTOSAN POLYSULFATE//ELMIRON//LASER ANIMAL MODEL | 125 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PENTOSAN POLYSULFATE | authKW | 364587 | 8% | 15% | 10 |
2 | ELMIRON | authKW | 325711 | 2% | 67% | 2 |
3 | LASER ANIMAL MODEL | authKW | 325711 | 2% | 67% | 2 |
4 | ABDOMINAL HEMORRHAGES | authKW | 244285 | 1% | 100% | 1 |
5 | ADULT SOLID TUMORS | authKW | 244285 | 1% | 100% | 1 |
6 | ANTITHROMBOGENIC SURFACE | authKW | 244285 | 1% | 100% | 1 |
7 | CALCIUM PENTOSAN POLYSULFATE CAPPS | authKW | 244285 | 1% | 100% | 1 |
8 | FIBRINOGEN ELIMINATION | authKW | 244285 | 1% | 100% | 1 |
9 | HEPARIN BINDING RECEPTORS | authKW | 244285 | 1% | 100% | 1 |
10 | HEPARINOIDS DERIVATIVE | authKW | 244285 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 1474 | 32% | 0% | 40 |
2 | Hematology | 1293 | 31% | 0% | 39 |
3 | Pharmacology & Pharmacy | 62 | 15% | 0% | 19 |
4 | Oncology | 27 | 10% | 0% | 12 |
5 | Medicine, Research & Experimental | 18 | 6% | 0% | 7 |
6 | Marine & Freshwater Biology | 15 | 4% | 0% | 5 |
7 | Chemistry, Medicinal | 15 | 4% | 0% | 5 |
8 | Physiology | 9 | 4% | 0% | 5 |
9 | Materials Science, Biomaterials | 8 | 2% | 0% | 2 |
10 | Rheumatology | 6 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SERV NEUROCIRUGIAFDN M FRE MED | 244285 | 1% | 100% | 1 |
2 | SNBTS BLOOD COMPONENTS ASSAY GRP | 244285 | 1% | 100% | 1 |
3 | UNIDAD INVEST NEUROCIENCIAS NEUROONCOL EXPT | 244285 | 1% | 100% | 1 |
4 | DOWPHARM | 81427 | 1% | 33% | 1 |
5 | ROYAL N SHORE HOSP SYDNEY | 48855 | 1% | 20% | 1 |
6 | BIOL MARINE FONDAMENTALE PL | 40712 | 1% | 17% | 1 |
7 | TRANSLAT ANGIOGENESIS GRP | 27141 | 1% | 11% | 1 |
8 | HOSP CLIN PUERTA HIERRO | 22206 | 1% | 9% | 1 |
9 | UNIV VET CAMDEN | 17447 | 1% | 7% | 1 |
10 | ONCOL DRUG PROD | 4360 | 1% | 2% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PERFUSION | 6738 | 2% | 1% | 3 |
2 | THROMBOSIS AND HAEMOSTASIS | 4143 | 10% | 0% | 13 |
3 | THROMBOSIS RESEARCH | 4033 | 10% | 0% | 13 |
4 | FIBRINOLYSIS | 3397 | 2% | 0% | 3 |
5 | COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES | 1899 | 2% | 0% | 3 |
6 | ARTERY | 1840 | 2% | 0% | 2 |
7 | JOURNAL OF TISSUE VIABILITY | 1835 | 1% | 1% | 1 |
8 | BOTANICA MARINA | 1682 | 3% | 0% | 4 |
9 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 828 | 2% | 0% | 3 |
10 | MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY | 648 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PENTOSAN POLYSULFATE | 364587 | 8% | 15% | 10 | Search PENTOSAN+POLYSULFATE | Search PENTOSAN+POLYSULFATE |
2 | ELMIRON | 325711 | 2% | 67% | 2 | Search ELMIRON | Search ELMIRON |
3 | LASER ANIMAL MODEL | 325711 | 2% | 67% | 2 | Search LASER+ANIMAL+MODEL | Search LASER+ANIMAL+MODEL |
4 | ABDOMINAL HEMORRHAGES | 244285 | 1% | 100% | 1 | Search ABDOMINAL+HEMORRHAGES | Search ABDOMINAL+HEMORRHAGES |
5 | ADULT SOLID TUMORS | 244285 | 1% | 100% | 1 | Search ADULT+SOLID+TUMORS | Search ADULT+SOLID+TUMORS |
6 | ANTITHROMBOGENIC SURFACE | 244285 | 1% | 100% | 1 | Search ANTITHROMBOGENIC+SURFACE | Search ANTITHROMBOGENIC+SURFACE |
7 | CALCIUM PENTOSAN POLYSULFATE CAPPS | 244285 | 1% | 100% | 1 | Search CALCIUM+PENTOSAN+POLYSULFATE+CAPPS | Search CALCIUM+PENTOSAN+POLYSULFATE+CAPPS |
8 | FIBRINOGEN ELIMINATION | 244285 | 1% | 100% | 1 | Search FIBRINOGEN+ELIMINATION | Search FIBRINOGEN+ELIMINATION |
9 | HEPARIN BINDING RECEPTORS | 244285 | 1% | 100% | 1 | Search HEPARIN+BINDING+RECEPTORS | Search HEPARIN+BINDING+RECEPTORS |
10 | HEPARINOIDS DERIVATIVE | 244285 | 1% | 100% | 1 | Search HEPARINOIDS+DERIVATIVE | Search HEPARINOIDS+DERIVATIVE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LUSH, RM , FIGG, WD , PLUDA, JM , BITTON, R , HEADLEE, D , KOHLER, D , REED, E , SARTOR, O , COOPER, MR , (1996) A PHASE I STUDY OF PENTOSAN POLYSULFATE SODIUM IN PATIENTS WITH ADVANCED MALIGNANCIES.ANNALS OF ONCOLOGY. VOL. 7. ISSUE 9. P. 939-944 | 19 | 73% | 20 |
2 | FAAIJ, RA , SRIVASTAVA, N , VAN GRIENSVEN, JMT , SCHOEMAKER, RC , KLUFT, C , BURGGRAAF, J , COHEN, AF , (1999) THE ORAL BIOAVAILABILITY OF PENTOSAN POLYSULPHATE SODIUM IN HEALTHY VOLUNTEERS.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 54. ISSUE 12. P. 929 -935 | 13 | 57% | 10 |
3 | MAFFRAND, JP , HERBERT, JM , BERNAT, A , DEFREYN, G , DELEBASSEE, D , SAVI, P , PINOT, JJ , SAMPOL, J , (1991) EXPERIMENTAL AND CLINICAL-PHARMACOLOGY OF PENTOSAN POLYSULFATE.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 17. ISSUE . P. 186-198 | 24 | 34% | 36 |
4 | DART, AJ , PERKINS, N , DOWLING, BA , BATTERHAM, T , LIVINGSTON, C , HODGSON, DR , (2001) THE EFFECT OF THREE DIFFERENT DOSES OF SODIUM PENTOSAN POLYSULPHATE ON HAEMATOLOGICAL AND HAEMOSTATIC VARIABLES IN ADULT HORSES.AUSTRALIAN VETERINARY JOURNAL. VOL. 79. ISSUE 9. P. 624-627 | 9 | 50% | 4 |
5 | SWAIN, SM , PARKER, B , WELLSTEIN, A , LIPPMAN, ME , STEAKLEY, C , DELAP, R , (1995) PHASE-I TRIAL OF PENTOSAN POLYSULFATE.INVESTIGATIONAL NEW DRUGS. VOL. 13. ISSUE 1. P. 55-62 | 9 | 56% | 13 |
6 | DEPROST, D , GUEROT, C , KARSENTY, F , (1985) PENTOSANE POLYSULFATE - THE EFFECT ON HEMOSTASIS OF A CONTINUOUS 3-DAY INFUSION.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 38. ISSUE 2. P. 171-175 | 8 | 80% | 6 |
7 | GIEDROJC, J , KLIMIUK, M , RADZIWON, P , KLOCZKO, J , BIELAWIEC, M , BREDDIN, HK , (1999) COMPARATIVE STUDY ON THE IN VITRO AND IN VIVO ACTIVITIES OF HEPARINOIDS DERIVATIVE INVESTIGATED ON THE ANIMAL MODEL.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 34. ISSUE 3. P. 340-345 | 10 | 33% | 2 |
8 | SIE, P , ALBAREDE, JL , ROBERT, M , BOULOUX, C , LANSEN, J , CHIGOT, C , CORRELL, S , THOUVENOT, JP , BONEU, B , (1986) TOLERANCE AND BIOLOGICAL-ACTIVITY OF PENTOSAN POLYSULFATE AFTER INTRAMUSCULAR OR SUBCUTANEOUS ADMINISTRATION FOR 10 DAYS IN HUMAN VOLUNTEERS.THROMBOSIS AND HAEMOSTASIS. VOL. 55. ISSUE 1. P. 86-89 | 8 | 73% | 14 |
9 | GIEDROJC, J , RADZIWON, P , KLIMIUK, M , BIELAWIEC, M , BREDDIN, HK , KLOCZKO, J , (1999) EXPERIMENTAL STUDIES ON THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF SODIUM AND CALCIUM PENTOSAN POLYSULPHATE.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 50. ISSUE 1. P. 111-119 | 8 | 38% | 8 |
10 | BROSSET, A , LAGRANGE, F , MERLE, L , (1994) HEPARINOIDES.THERAPIE. VOL. 49. ISSUE 5. P. 393-394 | 6 | 60% | 0 |
Classes with closest relation at Level 1 |